Bupropion Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Bupropion Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

Suicidality and Antidepressant Drugs
Use in Treating Psychiatric Disorders:
WARNINGS: Clinical Worsening and Suicide Risk in Treating Psychiatric DisordersPRECAUTIONS: Information for PatientsPRECAUTIONS: Pediatric Use
Use in Smoking Cessation Treatment:

Advise patients and caregivers that the patient using bupropion for smoking cessation should stop taking bupropion and contact a healthcare provider immediately if agitation, hostility, depressed mood, or changes in thinking or behavior that are not typical for the patient are observed, or if the patient develops suicidal ideation or suicidal behavior.


BUPROPION HYDROCHLORIDE DESCRIPTION


Bupropion Hydrochloride



CLINICAL PHARMACOLOGY

Pharmacodynamics:
Pharmacokinetics:
Absorption:
Distribution:
Metabolism:



PRECAUTIONS: Drug Interactions


Elimination:
Population Subgroups:
Hepatic:
WARNINGSPRECAUTIONSDOSAGE AND ADMINISTRATION
Renal:PRECAUTIONS: Renal Impairment
Left Ventricular Dysfunction:
Age:PRECAUTIONS: Geriatric Use
Gender:
Smokers:
CLINICAL TRIALS




INDICATIONS & USAGE


CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY

BUPROPION HYDROCHLORIDE CONTRAINDICATIONS







WARNINGS


Clinical Worsening and Suicide Risk in Treating Psychiatric Disorders:





All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases.


Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to healthcare providers. Such monitoring should include daily observation by families and caregivers.
Neuropsychiatric Symptoms and Suicide Risk in Smoking Cessation Treatment:(see BOXED WARNING, ADVERSE REACTIONS). These have included changes in mood (including depression and mania), psychosis, hallucinations, paranoia, delusions, homicidal ideation, hostility, agitation, aggression, anxiety, and panic, as well as suicidal ideation, suicide attempt, and completed suicide


Advise patients and caregivers that the patient using bupropion for smoking cessation should stop taking bupropion and contact a healthcare provider immediately if agitation, depressed mood, or changes in behavior or thinking that are not typical for the patient are observed, or if the patient develops suicidal ideation or suicidal behavior. In many postmarketing cases, resolution of symptoms after discontinuation of Zybanwas reported, although in some cases the symptoms persisted, therefore, ongoing monitoring and supportive care should be provided until symptoms resolve.

Screening Patients for Bipolar Disorder:
Bupropion-Containing Products:

  • ●     Dose: At doses of sustained-release bupropion up to a dose of 300 mg/day, the incidence of seizure is approximately 0.1% (1/1,000) and increases to approximately 0.4% (4/1,000) at the maximum recommended dose of 400 mg/day.






  • ●     Patient factors: Predisposing factors that may increase the risk of seizure with bupropion use include history of head trauma or prior seizure, central nervous system (CNS) tumor, the presence of severe hepatic cirrhosis, and concomitant medications that lower seizure threshold.
  • ●     Clinical situations: Circumstances associated with an increased seizure risk include, among others, excessive use of alcohol or sedatives (including benzodiazepines); addiction to opiates, cocaine, or stimulants; use of over-the-counter stimulants and anorectics; and diabetes treated with oral hypoglycemics or insulin.
  • ●     Concomitant medications: Many medications (e.g., antipsychotics, antidepressants, theophylline, systemic steroids) are known to lower seizure threshold.

  • ●     the total daily dose of bupropion hydrochloride extended-release tablets (SR) does not exceed 400 mg,
  • ●     the daily dose is administered twice daily, and
  • ●     the rate of incrementation of dose is gradual.
  • ●     No single dose should exceed 200 mg to avoid high peak concentrations of bupropion and/or its metabolites.


Potential for Hepatotoxicity:

PRECAUTIONS


General:












Cardiovascular Effects:



Hepatic Impairment:
CLINICAL PHARMACOLOGYWARNINGSDOSAGE AND ADMINISTRATION

Renal Impairment:


INFORMATION FOR PATIENTS



Clinical Worsening and Suicide Risk in Treating Psychiatric Disorders:
Neuropsychiatric Symptoms and Suicide Risk in Smoking Cessation Treatment:
Bupropion-Containing Products:








LABORATORY TESTS



DRUG INTERACTIONS







Drugs Metabolized By Cytochrome P450IID6 (CYP2D6):

MAO Inhibitors:CONTRAINDICATIONS
Levodopa and Amantadine:
Drugs That Lower Seizure Threshold:WARNINGS
Nicotine Transdermal System:PRECAUTIONS: Cardiovascular Effects
Alcohol:CONTRAINDICATIONS

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY

Teratogenic Effects:




LABOR & DELIVERY



NURSING MOTHERS



PEDIATRIC USE

BOX WARNINGWARNINGS: Clinical Worsening and Suicide Risk in Treating Psychiatric Disorders

GERIATRIC USE


CLINICAL PHARMACOLOGY
PRECAUTIONS: Renal ImpairmentDOSAGE AND ADMINISTRATION

BUPROPION HYDROCHLORIDE ADVERSE REACTIONS

WARNINGSPRECAUTIONS

Incidence in Controlled Trials With Bupropion:
Adverse Events Associated With Discontinuation of Treatment Among Patients Treated With Bupropion Hydrochloride Extended-Release Tablets (SR):


Adverse Events Occurring at an Incidence of 1% or More Among Patients Treated With Bupropion Hydrochloride Extended-Release Tablets (SR):



Incidence of Commonly Observed Adverse Events in Controlled Clinical Trials:
Bupropion Extended-release Tablets (SR) 300 mg/day:
Bupropion Extended-release Tablets (SR) 400 mg/day:
Other Events Observed During the Clinical Development and Postmarketing Experience of Bupropion:




Body (General):PRECAUTIONS
Cardiovascular:PRECAUTIONS
Digestive:
Endocrine:
Hemic and Lymphatic:
Metabolic and Nutritional:
Musculoskeletal:
Nervous System:
Respiratory:
Skin:
Special Senses:
Urogenital:

DRUG ABUSE AND DEPENDENCE

Controlled Substance Class:
Humans:


Animals:

OVERDOSAGE

Human Overdose Experience:

Overdosage Management:




DOSAGE & ADMINISTRATION

General Dosing Considerations:WARNINGS
Initial Treatment:
Increasing the Dosage Above 300 mg/day:
Maintenance Treatment:CLINICAL TRIALSCLINICAL PHARMACOLOGY
Dosage Adjustment for Patients with Impaired Hepatic Function:CLINICAL PHARMACOLOGYWARNINGSPRECAUTIONS
Dosage Adjustment for Patients with Impaired Renal Function:CLINICAL PHARMACOLOGYPRECAUTIONS

HOW SUPPLIED





STORAGE AND HANDLING



SPL MEDGUIDE

BuPROPion Hydrochloride Extended-release Tablets USP (SR)

What other important information should I know about bupropion hydrochloride extended-release tablets (SR)?
Antidepressant Medicines, Depression and Other Serious Mental Illnesses, and Suicidal Thoughts or Actions

Talk to your, or your family member's, healthcare provider about:
  • ●     all risks and benefits of treatment with antidepressant medicines
  • ●     all treatment choices for depression or other serious mental illness
What is the most important information I should know about antidepressant medicines, depression and other serious mental illnesses, and suicidal thoughts or actions?
     1. Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults within the first few months of treatment.

     2. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Some people may have a particularly high risk of having suicidal thoughts or actions.
     3. How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member?
  • ●               Pay close attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. This is very important when an antidepressant medicine is started or when the dose is changed.
  • ●               Call the healthcare provider right away to report new or sudden changes in mood, behavior, thoughts, or feelings.
  • ●               Keep all follow-up visits with the healthcare provider as scheduled. Call the healthcare provider between visits as needed, especially if you have concerns about symptoms.
Call a healthcare provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or worry you:
  • ●     thoughts about suicide or dying
  • ●     attempts to commit suicide
  • ●     new or worse depression
  • ●     new or worse anxiety
  • ●     feeling very agitated or restless
  • ●     panic attacks
  • ●     trouble sleeping (insomnia)
  • ●     new or worse irritability
  • ●     acting aggressive, being angry, or violent
  • ●     acting on dangerous impulses
  • ●     an extreme increase in activity and talking (mania)
  • ●     other unusual changes in behavior or mood
What else do I need to know about antidepressant medicines?
  •      Never stop an antidepressant medicine without first talking to a healthcare provider.Stopping an antidepressant medicine suddenly can cause other symptoms.
  •      Antidepressants are medicines used to treat depression and other illnesses.It is important to discuss all the risks of treating depression and also the risks of not treating it. Patients and their families or other caregivers should discuss all treatment choices with the healthcare provider, not just the use of antidepressants.
  •      Antidepressant medicines have other side effects.Talk to the healthcare provider about the side effects of the medicine prescribed for you or your family member.
  •      Antidepressant medicines can interact with other medicines.Know all of the medicines that you or your family member takes. Keep a list of all medicines to show the healthcare provider. Do not start new medicines without first checking with your healthcare provider.
  •      Not all antidepressant medicines prescribed for children are FDA approved for use in children. Talk to your child's healthcare provider for more information.

Quitting Smoking, Quit-Smoking Medications, Changes in Thinking and Behavior, Depression, and Suicidal Thoughts or Actions




  • ●     thoughts about suicide or dying
  • ●     attempts to commit suicide
  • ●     new or worse depression
  • ●     new or worse anxiety
  • ●     panic attacks
  • ●     feeling very agitated or restless
  • ●     acting aggressive, being angry, or violent
  • ●     acting on dangerous impulses
  • ●     an extreme increase in activity and talking (mania)
  • ●     abnormal thoughts or sensations
  • ●     seeing or hearing things that are not there (hallucinations)
  • ●     feeling people are against you (paranoia)
  • ●     feeling confused
  • ●     other unusual changes in behavior or mood


What Other Important Information Should I Know About Bupropion Hydrochloride Extended-release Tablets (SR)?
Seizures: There is a chance of having a seizure (convulsion, fit) with bupropion hydrochloride extended-release tablets (SR), especially in people:
  • ●     with certain medical problems.
  • ●     who take certain medicines.
. Do not take any other medicines while you are using bupropion hydrochloride extended-release tablets (SR) unless your doctor has said it is okay to take them.
If you have a seizure while taking bupropion hydrochloride extended-release tablets (SR), stop taking the tablets and call your doctor right away.
  •      High blood pressure (hypertension). Some people get high blood pressure, that can be severe, while taking bupropion hydrochloride extended-release tablets (SR).The chance of high blood pressure may be higher if you also use nicotine replacement therapy (such as a nicotine patch) to help you stop smoking.
  •      Severe allergic reactions. Some people have severe allergic reaction to bupropion hydrochloride extended-release tablets (SR). Stop taking bupropion hydrochloride extended-release tablets (SR) and call your doctor right awayif you get a rash, itching, hives, fever, swollen lymph glands, painful sores in the mouth or around the eyes, swelling of the lips or tongue, chest pain, or have trouble breathing. These could be signs of a serious allergic reaction.
  •      Unusual thoughts or behaviors.Some patients have unusual thoughts or behaviors while taking bupropion hydrochloride extended-release tablets (SR), including delusions (believe you are someone else), hallucinations (seeing or hearing things that are not there), paranoia (feeling that people are against you), or feeling confused. If this happens to you, call your doctor.
What are bupropion hydrochloride extended-release tablets (SR)?

Who should not take bupropion hydrochloride extended-release tablets (SR)?
Do not take bupropion hydrochloride extended-release tablets (SR) if you:

  • ●     have or had a seizure disorder or epilepsy.
  •      are taking Zyban(used to help people stop smoking) or any other medicines that contain bupropion hydrochloride, such as WellbutrinTablets or Wellbutrin XLExtended-Release Tablets.Bupropion is the same active ingredient that is in bupropion hydrochloride extended-release tablets (SR).
  • ●     drink a lot of alcohol and abruptly stop drinking, or use medicines called sedatives (these make you sleepy) or benzodiazepines and you stop using them all of a sudden.
  • ●     have taken within the last 14 days medicine for depression called a monoamine oxidase inhibitor (MAOI), such as Nardil(phenelzine sulfate), Parnate(tranylcypromine sulfate), or Marplan(isocarboxazid).
  • ●     have or had an eating disorder such as anorexia nervosa or bulimia.
  • ●     are allergic to the active ingredient in bupropion hydrochloride extended-release tablets (SR), bupropion, or to any of the inactive ingredients. See the end of this leaflet for a complete list of ingredients in bupropion hydrochloride extended-release tablets (SR).
What should I tell my doctor before using bupropion hydrochloride extended-release tablets (SR)?

  •      Tell your doctor about your other medical conditions including if you:
  •                are pregnant or plan to become pregnant.It is not known if bupropion hydrochloride extended-release tablets (SR) can harm your unborn baby.
  •                are breastfeeding.Bupropion passes through your milk. It is not known if bupropion can harm your baby.
  •                have liver problems,especially cirrhosis of the liver.
  • ●               have kidney problems.
  • ●               have an eating disorder such as anorexia nervosa or bulimia.
  • ●               have had a head injury.
  • ●               have had a seizure (convulsion, fit).
  • ●               have a tumor in your nervous system (brain or spine).
  • ●               have had a heart attack, heart problems, or high blood pressure.
  • ●               are a diabetic taking insulin or other medicines to control your blood sugar.
  • ●               drink a lot of alcohol.
  • ●               abuse prescription medicines or street drugs.
  •      Tell your doctor about all the medicines you take,including prescription and non- prescription medicines, vitamins, and herbal supplements. Many medicines increase your chances of having seizures or other serious side effects if you take them while you are using bupropion hydrochloride extended-release tablets (SR).
How should I take bupropion hydrochloride extended-release tablets (SR)?
  • ●     Take bupropion hydrochloride extended-release tablets (SR) exactly as prescribed by your doctor.
  •      Do not chew, cut, or crush bupropion hydrochloride extended-release tablets (SR).If you do, the medicine will be released into your body too quickly. If this happens you may be more likely to get side effects including seizures. You must swallow the tablets whole.Tell your doctor if you cannot swallow medicine tablets.
  • ●     Take bupropion hydrochloride extended-release tablets (SR) at the same time each day.
  • ●     Take your doses of bupropion hydrochloride extended-release tablets (SR) at least 8 hours apart.
  • ●     You may take bupropion hydrochloride extended-release tablets (SR) with or without food.
  • ●     If you miss a dose, do not take an extra tablet to make up for the dose you forgot. Wait and take your next tablet at the regular time.This is very important.Too many bupropion hydrochloride extended-release tablets (SR) can increase your chance of having a seizure.
  • ●     If you take too many bupropion hydrochloride extended-release tablets (SR), or overdose, call your local emergency room or poison control center right away.
  •      Do not take any other medicines while using bupropion hydrochloride extended-release tablets (SR) unless your doctor has told you it is okay.
  • ●     It may take several weeks for you to feel that bupropion hydrochloride extended-release tablets (SR) are working. Once you feel better, it is important to keep taking bupropion hydrochloride extended-release tablets (SR) exactly as directed by your doctor. Call your doctor if you do not feel bupropion hydrochloride extended-release tablets (SR) are working for you.
  • ●     Do not change your dose or stop taking bupropion hydrochloride extended-release tablets (SR) without talking with your doctor first.
What should I avoid while taking bupropion hydrochloride extended-release tablets (SR)?
  • ●     Do not drink a lot of alcohol while taking bupropion hydrochloride extended-release tablets (SR). If you usually drink a lot of alcohol, talk with your doctor before suddenly stopping. If you suddenly stop drinking alcohol, you may increase your chance of having seizures.
  • ●     Do not drive a car or use heavy machinery until you know how bupropion hydrochloride extended-release tablets (SR) affect you. Bupropion hydrochloride extended-release tablets (SR) can impair your ability to perform these tasks.
What are possible side effects of bupropion hydrochloride extended-release tablets (SR)?




How should I store bupropion hydrochloride extended-release tablets (SR)?
  • ●     Store bupropion hydrochloride extended-release tablets (SR) at room temperature. Store out of direct sunlight. Keep bupropion hydrochloride extended-release tablets (SR) in their tightly closed bottle.
  • ●     Bupropion hydrochloride extended-release tablets (SR) may have an odor.
General Information about bupropion hydrochloride extended-release tablets (SR).
  • ●     Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use bupropion hydrochloride extended-release tablets (SR) for a condition for which it was not prescribed. Do not give bupropion hydrochloride extended-release tablets (SR) to other people, even if they have the same symptoms you have. It may harm them. Keep bupropion hydrochloride extended-release tablets (SR) out of the reach of children.

What are the ingredients in bupropion hydrochloride extended-release tablets (SR)?





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Bupropion Hydrochloride

Bupropion Hydrochloride

Bupropion Hydrochloride

Bupropion Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-726(NDC:0591-3541)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
BUPROPION HYDROCHLORIDE BUPROPION 150 mg

Inactive Ingredients

Ingredient Name Strength
hydroxypropyl cellulose
cellulose, microcrystalline
SILICON DIOXIDE
STEARIC ACID
lactose monohydrate
MAGNESIUM STEARATE
HYDROCHLORIC ACID
titanium dioxide
polyethylene glycol

Product Characteristics

Color Size Imprint Code Shape
white 11 mm WPI;839 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-726-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077715 2011-08-25


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.